CASI Pharmaceuticals, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
CASI Pharmaceuticals, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2019 to Q4 2023.
  • CASI Pharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $948K, a 4.92% decline year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $948K -$49K -4.92% Dec 31, 2023 20-F 2024-03-28
Q4 2022 $997K -$443K -30.8% Dec 31, 2022 20-F 2024-03-28
Q4 2021 $1.44M -$642K -30.8% Dec 31, 2021 20-F 2024-03-28
Q4 2020 $2.08M -$499K -19.3% Dec 31, 2020 20-F 2024-03-28
Q4 2019 $2.58M Dec 31, 2019 20-F 2023-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.